A novel method using ultra-high performance liquid chromatography coupled to hybrid quadrupole-Orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap) was developed and validated for the simultaneous screening, identification and quantification of sedative-hypnotics in dietary supplements. Chromatographic conditions were optimised and a full data-dependent MS2 scan (MS/dd-MS2) in positive and negative ion mode was used. A single injection was sufficient to perform the simultaneous screening and identification/quantification of samples. The response showed a good linear relationship with analyte concentrations over wide ranges (e.g., 1.0–1000 ng g–1 for diazepam) with all the determination coefficients (r2) > 0.9985. The method was validated, obtaining accuracy (intra- and inter-day) in the range of 94.5–105.3% and precision (intra- and inter-day) in the range of 0.4–8.9%, respectively. The detection limits (LODs) were in the range of 0.3–1.0 ng g–1 for different analytes. Recoveries were performed and ranged from 74.1% to 90.2%, while all matrix effects were over the range of 85.4–93.6%. Finally, this method was used to detect sedative-hypnotics in commercial dietary supplements. Of a total of 45 batches of dietary supplements, only three batches were found to be positive samples with concentrations of diazepam, clonazepam and alprazolam at high levels (≥ 8.22 mg g–1).
1 January 2019 in Chinese Journal of Chromatography
A liquid chromatography-Orbitrap high resolution mass spectrometry (LC-HRMS) method and a TraceFinder database were developed for the screening and identification of 15 adulterated weight loss compounds in dietary supplements. The samples were extracted with methanol and filtered through a 0.22 mu m microfiltration membrane prior to LC-HRMS analysis. The Full MS/dd-MS2 mode was utilized in both positive and negative ion modes and the collected data were imported into the TraceFinder screening software. The established compound database and screening method were used for rapid, automatic, and high-precision screening to determine if the weight loss compounds were adulterated. The method validation results indicated that all of the analytes showed excellent linear relationships with regression coefficients (r) above 0.998. The recoveries were in the range of 79.7% - 95.4% while the precisions ranged from 3.3% to 8.7%. The method and database were used to screen weight loss adulterants in 29 batches of dietary supplements; six batches of samples tested positive for adulterants with the identification of four compounds including sibutramine. This method enables the automatic high-precision screening and identification of adulterants, providing a novel and powerful tool for combating the increasingly rampant occurrence of adulteration in dietary supplements.
1 January 2018 in Chinese Journal of Chromatography
A rapid, simple and sensitive ultra high performance liquid chromatography-tandem mass spectrometry ( UHPLC-MS/MS) method was developed for the determination of ambroxol hydrochloride in human plasma, and bioequivalence of its preparation was evaluated. The 50 mu L-plasma sample was treated with methanol for protein precipitation, while ambroxol-d5 was used as an internal standard ( IS). The separation was carried out on a Waters XBridge BEH C18 column (50 mmx2. 1 mm, 2.5 mu m) by gradient elution at a flow rate of 0.4 mL/min, with 0. 1% ( v/v) formic acid aqueous solution and methanol containing 0. 1% ( v/v) formic acid as the mobile phases. The analyte was detected using an electrospray ionization source in positive ion multiple reaction monitoring ( MEM) mode. The calibration curves were linear in the range of 2-400 ng/mL ( r= 0. 998). The intra- and inter-run accuracies were 97. 1%-108. 7%, the intra- and inter-run precisions were 1. 0%-5. 6%. The method was applied to the determination of the plasma concentration of the six healthy subjects after the oral administration of 30 mg of test and reference preparations. The bioavailability was ( 102. 3 +/- 14. 8 )%. The 90% confidence intervals of the test preparation' s pharmacokinetic parameters were 80. 0%-125. 0% of the reference preparation' s corresponding parameters. Thus , it is proved that the test preparation and reference preparation are bioequivalent.